Back to search
FDAFDA · Food and drugs·Recall number Z-1512-2017

Mammotome Revolve Dual Vacuum Assist Biopsy System The device is used to sample breast tissue that has been identified as suspicious under imaging guidance

Published March 29, 2017 · Recall initiated: February 28, 2017

Summary

FDA records medical device Class II recall Z-1512-2017, published March 29, 2017 and initiated February 28, 2017. Recalling firm: Devicor Medical Products Inc; Status: Terminated; Reported quantity: 320; Lot: F11621304D1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The device did not have Revolve Stereo Probe labeling, no product code indicating the size and length of the probe, no sterilization sticker or lot number.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Devicor Medical Products Inc
Distributor
Worldwide Distribution - US including IA, IL, NY, OH, OK, PA, TN & WV. Internationally to Chile and Brazil
Lot
F11621304D1
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Mammotome Revolve Dual Vacuum Assist Biopsy System The device is used to sample breast tissue that has been identified as suspicious under imaging guidance recalled?

Yes. FDA published recall Z-1512-2017 on March 29, 2017. Reported hazard: The device did not have Revolve Stereo Probe labeling, no product code indicating the size and length of the probe, no sterilization sticker or lot number.

What should I do if I have this product?

Voluntary: Firm initiated · Letter